First Eagle Investments started to build up the position in Intra-Cellular Therapies in Q2 2014. Since then they sold 17.5 Thousand shares. The investor sold all their shares in Q3 2014 and doesn't own any shares in Intra-Cellular Therapies anymore.
Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 5.7% during the 3rd qu...
ClearBridge Investments, an investment management firm, published its “Small Cap Strategy” fourth quarter 2021 investor letter – a copy of which can be downl...
I feature a lot of big winners over the years inside IBI. Some of our big winners include TG Therapeutics (TGTX), CRISPR Therapeutics (CRSP), CryoPort (CYRX)...